Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes
Background Type 2 diabetes (T2D) and obesity are associated with nonalcoholic fatty liver disease, cardiomyopathy, and cardiovascular mortality. Both show stronger links between ectopic and visceral fat deposition, and an increased cardiometabolic risk compared with subcutaneous fat. Objectives This study investigated whether lean patients (Ln) with T2D exhibit increased ectopic and visceral fat deposition and whether these are linked to cardiac and hepatic changes. Methods Twenty seven obese patients (Ob) with T2D, 15 Ln T2D, and 12 normal weight control subjects were studied. Subjects underwent cardiac computed tomography, cardiac magnetic resonance imaging (MRI) proton and phosphorus MR spectroscopy, and multiparametric liver MR, including hepatic proton MRS, T1 and T2* mapping yielding "iron corrected T1" [cT1] Results Diabetes, with or without obesity, was associated with increased myocardial triglyceride content (p 0.01) increased hepatic triglyceride content (p 0.04) and impaired myocardial energetics (p 0.04) Although cardiac structural changes, steatosis, and energetics were similar between the T2D groups, epicardial fat (p 0.04) hepatic triglyceride (p 0.01) and insulin resistance (p 0.03) were higher in Ob T2D. Epicardial fat, hepatic triglyceride, and insulin resistance correlated negatively with systolic strain and diastolic strain rates, which were only significantly impaired in Ob T2D (p 0.001 and p 0.006, respectively) Fibroinflammatory liver disease (elevated cT1) was only evident in Ob T2D patients. cT1 correlated with hepatic and epicardial fat (p 0.001 and p 0.01, respectively) Conclusions Irrespective of body mass index, diabetes is related to significant abnormalities in cardiac structure, energetics, and cardiac and hepatic steatosis. Obese patients with T2D show a greater propensity for ectopic and visceral fat deposition.
Journal of the American College of Cardiology